SaaS Metrics
Abstract
Circulating tumor DNA (ctDNA) detection can predict clinical risk in early-stage tumors. However, clinical applications are constrained by the sensitivity of clinically validated ctDNA detection approaches. NeXT Personal is a whole-genome-based, tumor-informed platform that has been analytically validated for ultrasensitive ctDNA detection at 1–3 ppm of ctDNA with 99.9% specificity. Through an analysis of 171 patients with early-stage lung cancer from the TRACERx study, we detected ctDNA pre-operatively within 81% of patients with lung adenocarcinoma (LUAD), including 53% of those with pathological TNM (pTNM) stage I disease. ctDNA predicted worse clinical outcome, and patients with LUAD with
Academic Publication Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
Research Abstract & Technology Focus
AI Semantic Synergy Context
Connecting this academic literature to real-world market discussions and products.
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
Abstract Circulating tumor DNA (ctDNA) detection can predict clinical risk in early-stage tumors. However, clinical applications are constrained by the sensitivity of clinically v...
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer
Abstract Understanding the role of the tumor microenvironment (TME) in lung cancer is critical to improving patient outcomes. We identifi...
Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges
AbstractCirculating tumor DNA (ctDNA) methylation, an innovative liquid biopsy biomarker, has emerged as a promising tool in early cancer diagnosis, monitoring, and prognosis prediction. As a nonin...
Analysis of cell-free DNA for cancer diagnostics using liquid biopsies
Chromatin organisation influences gene regulation and genome stability, yet its dysregulation in cancer remains incompletely understood. This has become particularly important for patient diagnosti...
A novel Deep Learning architecture for lung cancer detection and diagnosis from Computed Tomography image analysis
No description provided.
Frequently Asked Questions (FAQ)
Curated market intelligence mapped to this research.
What is the core focus of the research titled 'Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma'?
This literature focuses on: Abstract Circulating tumor DNA (ctDNA) detection can predict clinical risk in early-stage tumors. However, clinical applications are constrained by the sensitivity of clinically validated ctDNA detection approaches. NeXT Personal...
Are there open-source GitHub repositories related to Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma?
Yes, open-source projects like feder-cr/invisible_playwright (AI Browser, Stealth Firefox that passes every bot detection test. Drop-in Playwright replacement.) are actively building upon these concepts.
What other academic literature is closely related to 'Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma'?
Yes, highly correlated activity was mapped. An entry titled 'Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma' discusses this: Abstract Circulating tumor DNA (ctDNA) detection can predict clinical risk in early-stage tumors. However, clinical applications ...
Cite this Market Intelligence Report
Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.
Commercial Realization
Startups and Open Source tools heavily associated with the concepts explored in this paper.
-
GitHubfeder-cr/invisible_playwright
-
GitHubkhrisat/text-humanizer